Making an Impact

  • “We’ve been a client of the Therapeutic Innovations Group for nearly 6 months and working with them has been a pleasure. They guided us through discovery and optimization of a complex biologic, flagged the critical risks and levers, and set us up for the next phase. Their strategic judgment and hands-on execution are moving our program toward IND readiness. I strongly recommend them as an innovative, dependable partner in biologics development.”

    Kristen Fortney, PhD

    CEO

    BIOAGE

  • “Working with the Therapeutic Innovations Group has been a huge asset to our discovery efforts. Not only do they bring extensive experience in antibody engineering (across a variety of formats), but they're exceptional to work with: responsive, collaborative, and thorough.”

    TIG Client

  • Mike brings a potent combination of deep technical expertise in antibody-based therapeutics and genetically engineered cell therapies, decades of drug development experience, and creative thinking that make him uniquely suited to tackle the hardest problems in drug discovery. Whether troubleshooting a stalled program or building a strategy from the ground up, Mike delivers a highly organized and practical approach all while being one of the most reliable and trustworthy people I've ever worked with.

    Mark Wallet, PhD

    CSO

    Link Cell Therapies

  • We engaged TIG for a four-session crash course on antibody development workflows, and it was exactly what we needed. The TIG team quickly understood our context and motivations, and delivered genuinely practical insights across the full development pipeline -- from target design and hit generation through candidate selection. What stood out was their willingness to ground the discussion in real-world examples, walking through actual workflows and technical details rather than staying at a high level. The sessions were engaging and collaborative, with a lot of back and forth that made it feel like a real dialogue rather than a lecture. We came away with a much clearer picture of industry workflows and emerging trends that directly informed our thinking. We wouldn't hesitate to engage them again.New List Item

    TIG Client

  • We work with Therapeutics Innovations Group on a new avenue to support early stage companies using software technology in the biotech industry. Mike provided generous insight with impact, driven by both experience and the awareness to observe structural changes in the industry that drive trends, allowing us to act early before we joined crowded spaces. I cannot imagine a better connection to the world of drug discovery, antibodies, and cell and gene therapies than TIG, especially if you are looking for mentoring that transcends technical and strategic support and drives human teams to be better leaders.

    Ross Martin-Wells, PhD

    CEO

    Lab Belay, LLC